Integrative, age-related changes in genome and epigenome in human lung in relation to smoking
Integrative, age-related changes in genome and epigenome in human lung in relation to smoking
批准号:
10320918
负责人:
SIMON D SPIVACK
金额:
$66.36万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-01 至 2023-12-31
关键词:
AffectAgeAgingAirway DiseaseAneuploidyCell AgingCell NucleusCell divisionCellsChromosome abnormalityChronic Obstructive Pulmonary DiseaseComplexCopy Number PolymorphismCytosineDNADNA DamageDNA MethylationDNA RepairDNA Sequence AlterationDNA StructureDNA biosynthesisDataDepurinationDetectionDevelopmentDiseaseEarly DiagnosisEnvironmental Risk FactorEpigenetic ProcessFutureGene ExpressionGeneticGenetic CodeGenetic TranscriptionGenomeGenomic InstabilityGenomicsHumanIndividualLeadLinkLungLung diseasesMalignant NeoplasmsMapsMethodsMethylationMolecularMutationNoiseNormal tissue morphologyOrganPatternPreventionPulmonary FibrosisRetrotranspositionRiskRisk FactorsSamplingSmokerSmokingSourceStressTestingTherapeuticTimeTobacco smokeVariantage relatedbasebronchial epitheliumcigarette smokingcrosslinkenvironmental tobacco smoke exposureepigenomeepigenomicsfunctional losshuman tissuemethylation patternmethylomemethylomicsnon-smokernormal agingrepairedresponsesingle cell analysissingle-cell RNA sequencingtobacco exposuretobacco smoke exposuretranscriptometranscriptomics
中文摘要
摘要
衰老是许多与年龄相关的肺部疾病的主要危险因素,包括COPD和肺纤维化。它
据推测,这种衰老与疾病的关系是由于多种遗传因素的复杂相互作用,
表观遗传学和转录组学改变随时间发生在正常人肺中。反过来,这些与年龄有关的
这些变化受到环境因素的影响,例如吸烟。不幸的是,
与年龄相关的人类肺部分子改变这在某种程度上是由于缺乏分析的方法
人体组织中随机发生的变化,即,影响不同细胞中的单个细胞或细胞群
的方式最好的例子是基因组的不稳定性,这是衰老的标志之一。基因组不稳定性可以定义为
遗传密码的变化,从大的染色体畸变,到较小的缺失,插入,
拷贝数变异和碱基替换突变。基因组不稳定的根本原因是
细胞分裂、DNA复制或DNA损伤修复过程中的错误。这种变化是不可逆转的,
与可以修复的DNA损伤形成鲜明对比。DNA损伤涉及细胞的物理变化
DNA结构,例如,断裂、脱嘌呤、脱嘧啶、交联、修饰碱基。不幸的是,
正常组织中的突变在细胞与细胞之间是不同的,除了使用单细胞外,
就像我们在项目中所做的那样。然而,在衰老过程中,
也引起DNA损伤反应,这可能导致多种表观遗传改变,
从细胞到细胞,并且可以在大量DNA中检测到。此外,与年龄有关的变化的随机模式是
可能发生在老化过程中,其检测需要单细胞方法。在此,我们建议
全面分析人肺支气管上皮细胞的随机和适应性变化,
基因组、表观基因组和转录组。该项目将整合这些全面的基因组谱,
正常人支气管上皮细胞表观基因组变化与年龄和烟草烟雾暴露的关系。
这将为今后肺部疾病状态的比较提供参考数据,
年龄和吸烟相关的肺部疾病的机制,从而促进早期发展,
检测、预防和治疗策略。
英文摘要
ABSTRACT
Aging is the main risk factor for many age-related lung diseases, including COPD and pulmonary fibrosis. It
has been speculated that this aging-disease relationship is due to the complex interaction of multiple genetic,
epigenetic and transcriptomic alterations that occur in normal human lung over time. In turn, these age-related
changes are impacted by environmental factors, such as cigarette smoking. Unfortunately, little is known about
age-related molecular alterations in human lung. To some extent this is due to the lack of methods to analyze
human tissues for changes occurring stochastically, i.e., affecting individual cells or groups of cells in different
ways. The best example is genome instability, one of the hallmarks of aging. Genome instability can be defined
as changes in the genetic code, varying from large chromosomal aberrations, to smaller deletions, insertions
and copy number variation, and base substitution mutations. The underlying causes of genome instability are
errors during cell division, DNA replication or DNA repair of DNA damage. Such changes are irreversible and
are in striking contrast to DNA damage, which can be repaired. DNA damage involves physical alterations in
DNA structure, e.g., breaks, depurination, depyrimidination, crosslinks, modified bases. Unfortunately,
mutations in normal tissues are different from cell to cell and very difficult to study, except using single cell
approaches as we will do in the proposed project. However, DNA damage induced in the lung during aging
also evokes a DNA damage response, which can lead to multiple epigenetic alterations that are consistent
from cell to cell and can be detected in bulk DNA. In addition, a stochastic pattern of age-related changes is
likely to occur during aging, the detection of which requires a single cell approach. Here we propose to
comprehensively analyze human lung bronchial epithelium for both stochastic and adaptive changes in the
genome, epigenome and transcriptome. This project will integrate these comprehensive spectra of genomic
and epigenomic change of normal human bronchial epithelium in relation to age and tobacco smoke exposure.
This will provide reference data for future comparisons of lung disease states, enhance our understanding of
age-and smoking-related mechanisms of lung disease, and thereby facilitate the development of early
detection, prevention and therapeutic strategies.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1111/acel.13184
发表时间:
2020-09
期刊:
Aging cell
影响因子:
7.8
作者:
[White RR, Maslov AY, Lee M, Wilner SE, Levy M, Vijg J]
通讯作者:
Vijg J
DOI:
10.1038/s42255-020-0247-0
发表时间:
2020-08
期刊:
Nature metabolism
影响因子:
20.8
作者:
[Zhang ZD, Milman S, Lin JR, Wierbowski S, Yu H, Barzilai N, Gorbunova V, Ladiges WC, Niedernhofer LJ, Suh Y, Robbins PD, Vijg J]
通讯作者:
Vijg J
DOI:
10.1126/sciadv.abm3259
发表时间:
2022-04-08
期刊:
Science advances
影响因子:
13.6
作者:
[Maslov AY, Makhortov S, Sun S, Heid J, Dong X, Lee M, Vijg J]
通讯作者:
Vijg J
Integrative, age-related changes in genome and epigenome in human lung in relation to smoking
-
批准号:9895468
-
项目类别:
-
资助金额:$65.23万
-
财政年份:2019
-
负责人:SIMON D SPIVACK
-
依托单位:
Assessing genome sequence integrity in normal human cells
-
批准号:10408704
-
项目类别:
-
资助金额:$66.61万
-
财政年份:2018
-
负责人:SIMON D SPIVACK
-
依托单位:
Assessing genome sequence integrity in normal human cells
-
批准号:10158475
-
项目类别:
-
资助金额:$65.71万
-
财政年份:2018
-
负责人:SIMON D SPIVACK
-
依托单位:
Assessing genome sequence integrity in normal human cells
-
批准号:9759931
-
项目类别:
-
资助金额:$65.71万
-
财政年份:2018
-
负责人:SIMON D SPIVACK
-
依托单位:
Clinical characteristics and outcomes of WTC-associated Sarcoidosis
-
批准号:9275649
-
项目类别:
-
资助金额:$49.23万
-
财政年份:2015
-
负责人:SIMON D SPIVACK
-
依托单位:
Exhaled microRNAs leveraged for lung cancer risk assessment
-
批准号:8815714
-
项目类别:
-
资助金额:$10.76万
-
财政年份:2014
-
负责人:SIMON D SPIVACK
-
依托单位:
Exhaled microRNAs leveraged for lung cancer risk assessment
-
批准号:9122812
-
项目类别:
-
资助金额:$11.03万
-
财政年份:2014
-
负责人:SIMON D SPIVACK
-
依托单位:
Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarker
-
批准号:7796405
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2010
-
负责人:SIMON D SPIVACK
-
依托单位:
Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarker
-
批准号:8109307
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2010
-
负责人:SIMON D SPIVACK
-
依托单位:
Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarker
-
批准号:8506992
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2010
-
负责人:SIMON D SPIVACK
-
依托单位:
Risk for Lung Cancer, Asthma, and COPD; Integrating Clinical and Airway Biomarker
-
批准号:8284170
-
项目类别:
-
资助金额:$16.77万
-
财政年份:2010
-
负责人:SIMON D SPIVACK
-
依托单位:
Risk for Lung Cancer Asthma and COPD; Integrating Clinical and Airway Biomarker
-
批准号:9122683
-
项目类别:
-
资助金额:$4.66万
-
财政年份:2010
-
负责人:SIMON D SPIVACK
-
依托单位:
Early Functional Genetic and Epigenetic Changes in Human Lung Carcinogenesis
-
批准号:7817299
-
项目类别:
-
资助金额:$49.96万
-
财政年份:2009
-
负责人:SIMON D SPIVACK
-
依托单位:
Early Functional Genetic and Epigenetic Changes in Human Lung Carcinogenesis
-
批准号:7941936
-
项目类别:
-
资助金额:$49.92万
-
财政年份:2009
-
负责人:SIMON D SPIVACK
-
依托单位:
Exhaled Breath DNA Methylation in Lung Carcinogenesis
-
批准号:7666658
-
项目类别:
-
资助金额:$18.68万
-
财政年份:2008
-
负责人:SIMON D SPIVACK
-
依托单位:
Exhaled Breath DNA Methylation in Lung Carcinogenesis
-
批准号:7533238
-
项目类别:
-
资助金额:$23.51万
-
财政年份:2008
-
负责人:SIMON D SPIVACK
-
依托单位:
Individual Promoter SNP and CpG Methylation Signatures
-
批准号:7031040
-
项目类别:
-
资助金额:$14.9万
-
财政年份:2005
-
负责人:SIMON D SPIVACK
-
依托单位:
Individual Promoter SNP and CpG Methylation Signatures
-
批准号:6926610
-
项目类别:
-
资助金额:$15.3万
-
财政年份:2005
-
负责人:SIMON D SPIVACK
-
依托单位:
Quantitative Gene Expression in Human Lung Epithelium
-
批准号:7228465
-
项目类别:
-
资助金额:$20.02万
-
财政年份:2003
-
负责人:SIMON D SPIVACK
-
依托单位:
Quantitative Gene Expression in Human Lung Epithelium
-
批准号:6764070
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2003
-
负责人:SIMON D SPIVACK
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: